|
| General Information |
| Business: |
We are a pharmaceutical company focused on the development of therapeutics to treat kidney disease, an area of significant unmet medical need. Since our inception, we have collaborated with the world’s leading experts in kidney disease and leveraged our knowledge of pathogenic oxidative chemistries to build a strong portfolio of intellectual property and to advance the development of our drug candidates. We believe that our comprehensive effort to develop a new generation of therapeutics that target kidney disease provides us with a leadership position in this large and attractive market. |
|
| Industry: |
PHARMACEUTICAL PREPARATIONS |
|
| Employees: |
3 |
Founded: |
2004 |
|
| Contact Information |
| Address: |
79 T.W. Alexander Drive 4401, Research Commons Building, Suite 290, P.O. Box 14188, Research Triangle Park, NC 27709, US |
|
|
|
|
|
|
|
| Financial Information |
| |
| Revenues: |
$ 0.0 mil (last 12 months) |
|
| Net Income: |
$ -2.2 mil (last 12 months) |
|
| IPO Profile |
|
|
|
|
